Clinical Trials Directory

Trials / Terminated

TerminatedNCT05269069

Impact of Rheumatoid Arthritis on Body Composition, Bone Marrow Adiposity and Bone Mineral Density: a Case-control Study

Status
Terminated
Phase
Study type
Observational
Enrollment
52 (actual)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

During rheumatoid arthritis (RA) (in comparison with control subjects), body composition is altered with a loss of lean body mass, bone mass and an accumulation of fat mass. Determination of total body fat and particularly its abdominal distribution (visceral adiposity) is important because of the cardiovascular (excess cardiovascular risk), metabolic (insulin resistance, diabetes and dyslipidemia) and bone (increased fracture risk) risks associated with this endocrine organ. Moreover, we do not have data concerning medullary adiposity in RA. This pilot case-control study will be compare body composition, bone marrow adiposity and bone mineral density in patients with RA versus healthy volunteers.

Conditions

Interventions

TypeNameDescription
OTHERAssessment of body composition, bone mineral density and bone marrow adiposity.DXA for body composition and bone mineral density, MRI for bone marrow adiposity and blood tests (leptine, CTX, P1NP)

Timeline

Start date
2022-08-17
Primary completion
2024-04-02
Completion
2024-04-02
First posted
2022-03-07
Last updated
2024-05-16

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05269069. Inclusion in this directory is not an endorsement.